Invasive fungal infections: evolving challenges for diagnosis and therapeutics
- 12 March 2002
- journal article
- case report
- Published by Elsevier in Molecular Immunology
- Vol. 38 (12-13) , 947-957
- https://doi.org/10.1016/s0161-5890(02)00022-6
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Mortality and Costs of Acute Renal Failure Associated with Amphotericin B TherapyClinical Infectious Diseases, 2001
- Lipid-based Antifungal Agents Current StatusCurrent Pharmaceutical Design, 2001
- Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With NeutropeniaJournal of Clinical Oncology, 2001
- Reliability of clinical research on invasive fungal infections: a systematic review of the literatureMedical Mycology, 2001
- Amphotericin B preparations: a maximum tolerated dose in severe invasive fungal infections?Transplant Infectious Disease, 2000
- Efficacy of Low-Dose Dopamine in Preventing Amphotericin B Nephrotoxicity in Bone Marrow Transplant Patients and Leukemia PatientsAntimicrobial Agents and Chemotherapy, 1998
- Comparison of Serum Galactomannan Antigen Detection and Competitive Polymerase Chain Reaction for Diagnosing Invasive AspergillosisClinical Infectious Diseases, 1998
- A New Classification and Diagnostic Criteria for Invasive Fungal SinusitisJAMA Otolaryngology–Head & Neck Surgery, 1997
- The Epidemiology of Hematogenous Candidiasis Caused by Different Candida SpeciesClinical Infectious Diseases, 1997
- Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosisAntimicrobial Agents and Chemotherapy, 1994